GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prestige BioPharma Ltd (XKRX:950210) » Definitions » Total Equity

Prestige BioPharma (XKRX:950210) Total Equity : ₩493,395 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Prestige BioPharma Total Equity?

Prestige BioPharma's total equity for the quarter that ended in Dec. 2024 was ₩493,395 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Prestige BioPharma Total Equity Historical Data

The historical data trend for Prestige BioPharma's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prestige BioPharma Total Equity Chart

Prestige BioPharma Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24
Total Equity
137,799.46 574,960.66 429,935.86 546,234.80 515,501.85

Prestige BioPharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 511,549.06 516,163.46 515,501.85 488,546.30 493,394.70

Prestige BioPharma Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Prestige BioPharma's Total Equity for the fiscal year that ended in Jun. 2024 is calculated as

Total Equity=Total Assets(Q: Jun. 2024 )-Total Liabilities(Q: Jun. 2024 )
=711720.463-196218.614
=515,502

Prestige BioPharma's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=756457.669-263062.965
=493,395

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Prestige BioPharma Total Equity Related Terms

Thank you for viewing the detailed overview of Prestige BioPharma's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Prestige BioPharma Business Description

Traded in Other Exchanges
N/A
Address
2 Science Park Drive No. 04-13/14, Ascent Tower B, Singapore Science Park, Singapore, SGP, 118222
Prestige BioPharma Ltd is a biopharmaceutical company. The company is focused on the development of biosimilars and new antibody therapeutics. It focuses on oncology and immune disorders, developing new and similar antibody drugs for solid tumor, pancreatic cancer, and arthritis.

Prestige BioPharma Headlines

No Headlines